Advances in the management of idiopathic pulmonary fibrosis

Jay H. Ryu; Craig E. Daniels

doi:10.3410/M2-28

Advances in the management of idiopathic pulmonary fibrosis

Jay H. Ryu, Craig E. Daniels

Pulmonary and Critical Care Medicine

Research output: Contribution to journal › Review article › peer-review

9 Scopus citations

Abstract

Idiopathic pulmonary fibrosis (IPF) is a common form of interstitial lung disease and usually results in progressive respiratory insufficiency and death. Steady progress has been made in understanding the pathogenesis of IPF and multiple clinical trials are ongoing, but effective therapy remains elusive.

Original language	English (US)
Article number	28
Journal	F1000 Medicine Reports
Volume	2
Issue number	1
DOIs	https://doi.org/10.3410/M2-28
State	Published - Apr 12 2010

ASJC Scopus subject areas

General Medicine

Access to Document

10.3410/M2-28

Cite this

@article{bd99005ec72a4658b9ad55930bff3d21,

title = "Advances in the management of idiopathic pulmonary fibrosis",

abstract = "Idiopathic pulmonary fibrosis (IPF) is a common form of interstitial lung disease and usually results in progressive respiratory insufficiency and death. Steady progress has been made in understanding the pathogenesis of IPF and multiple clinical trials are ongoing, but effective therapy remains elusive.",

author = "Ryu, {Jay H.} and Daniels, {Craig E.}",

year = "2010",

month = apr,

day = "12",

doi = "10.3410/M2-28",

language = "English (US)",

volume = "2",

journal = "F1000 Medicine Reports",

issn = "1757-5931",

publisher = "Medicine Reports Limited",

number = "1",

}

TY - JOUR

T1 - Advances in the management of idiopathic pulmonary fibrosis

AU - Ryu, Jay H.

AU - Daniels, Craig E.

PY - 2010/4/12

Y1 - 2010/4/12

N2 - Idiopathic pulmonary fibrosis (IPF) is a common form of interstitial lung disease and usually results in progressive respiratory insufficiency and death. Steady progress has been made in understanding the pathogenesis of IPF and multiple clinical trials are ongoing, but effective therapy remains elusive.

AB - Idiopathic pulmonary fibrosis (IPF) is a common form of interstitial lung disease and usually results in progressive respiratory insufficiency and death. Steady progress has been made in understanding the pathogenesis of IPF and multiple clinical trials are ongoing, but effective therapy remains elusive.

UR - http://www.scopus.com/inward/record.url?scp=77955061939&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955061939&partnerID=8YFLogxK

U2 - 10.3410/M2-28

DO - 10.3410/M2-28

M3 - Review article

AN - SCOPUS:77955061939

SN - 1757-5931

VL - 2

JO - F1000 Medicine Reports

JF - F1000 Medicine Reports

IS - 1

M1 - 28

ER -

Advances in the management of idiopathic pulmonary fibrosis

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this